VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,686,027 | +156.0% | 1,727,646 | +199.7% | 0.00% | – |
| Q2 2023 | $9,253,611 | +292.1% | 576,549 | +89.6% | 0.00% | – |
| Q1 2023 | $2,360,181 | -76.2% | 304,147 | -40.8% | 0.00% | – |
| Q4 2022 | $9,934,136 | +86.6% | 513,392 | +105.5% | 0.00% | – |
| Q3 2022 | $5,323,000 | +76.0% | 249,783 | +12.4% | 0.00% | – |
| Q2 2022 | $3,025,000 | -23.7% | 222,255 | +31.7% | 0.00% | – |
| Q1 2022 | $3,964,000 | +20.3% | 168,757 | +36.9% | 0.00% | – |
| Q4 2021 | $3,294,000 | +152.2% | 123,273 | +63.8% | 0.00% | – |
| Q3 2021 | $1,306,000 | – | 75,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |